Lactobacillus casei improves resistance to pneumococcal respiratory infection in malnourished mice.
- 2005-06
- The Journal of Nutrition 135(6)
- J. Villena
- S. Racedo
- Graciela Agüero
- E. Bru
- M. Medina
- S. Alvarez
- PubMed: 15930453
- DOI: 10.1093/JN/135.6.1462
Abstract
We studied the effect of Lactobacillus casei CRL 431 used as a supplement in a repletion diet on the resistance to Streptococcus pneumoniae respiratory infection in malnourished mice. Weaned mice were malnourished after they consumed a protein-free diet (PFD) for 21 d. Malnourished mice were fed a balanced conventional diet (BCD) with or without supplemental L. casei for 7, 14, or 21 consecutive days, or BCD for 7 d with L. casei supplementation on d 6 and 7 (7dBCD+2dLc). The malnourished control (MNC) group was fed only the PFD, whereas well-nourished control (WNC) mice consumed the BCD ad libitum. Mice were challenged with S. pneumoniae at the end of each dietary treatment. Lung colonization and bacteremia were significantly greater in MNC than in WNC. Normalization of the immune response occurred in malnourished mice fed the BCD for 21 d. L. casei supplementation reduced the time required for a normal response from 21 to 7 d. Mice administered the 7dBCD+2dLc repletion treatment had a more effective pathogen clearance from blood and significantly lower lung damage than MNC. This treatment improved both the number of leukocytes and neutrophils in blood and bronchoalveolar lavages (BAL) and the bactericidal function of phagocytic cells to levels that did not differ from those of WNC. In the 7dBCD+2dLc mice, antipneumococcal IgA in BAL was higher than in WNC, whereas antipneumococcal IgG in serum and BAL did not differ. This study suggests that the addition of L. casei to the repletion diet has a beneficial effect because it accelerates the recovery of the innate immune response and improves the specific immune mechanisms against an S. pneumoniae respiratory infection in malnourished mice.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Lacticaseibacillus casei | Elevated Antipneumococcal IgA Levels in Bronchoalveolar Lavage Fluid | Beneficial | Moderate |
Lacticaseibacillus casei | Improved Immune Mechanisms Against S. pneumoniae | Beneficial | Large |
Lacticaseibacillus casei | Improved Immune Response | Beneficial | Large |
Lacticaseibacillus casei | Improved Pathogen Clearance | Beneficial | Large |
Lacticaseibacillus casei R0215 | Elevated Antipneumococcal IgA Levels in Bronchoalveolar Lavage Fluid | Beneficial | Moderate |
Lacticaseibacillus casei R0215 | Improved Resistance to Pneumococcal Respiratory Infection | Beneficial | Large |
Lactobacillus casei | Enhanced Antipneumococcal IgA Levels in BAL | Beneficial | Moderate |
Lactobacillus casei | Enhanced Immune Response | Beneficial | Large |
Lactobacillus casei | Improved Bactericidal Function of Phagocytic Cells | Beneficial | Moderate |
Lactobacillus casei | Improved Pathogen Clearance | Beneficial | Large |
Lactobacillus casei HA-108 | Enhanced Antipneumococcal IgA Levels in BAL | Beneficial | Moderate |
Lactobacillus casei HA-108 | Improved Innate Immune Response | Beneficial | Large |
Lactobacillus casei HA-108 | Improved Pathogen Clearance | Beneficial | Large |
Lactobacillus casei Lc-11 | Elevated Antipneumococcal IgA Levels in Bronchoalveolar Lavage Fluid | Beneficial | Moderate |
Lactobacillus casei Lc-11 | Improved Immune Response | Beneficial | Large |
Lactobacillus casei Lc-11 | Improved Pathogen Clearance | Beneficial | Large |
Lactobacillus casei LC03 | Improved Immune Cell Function | Beneficial | Large |
Lactobacillus casei LC03 | Improved Pathogen Clearance from Blood | Beneficial | Large |
Lactobacillus casei LC03 | Improved Respiratory Infection Resistance | Beneficial | Large |
Lactobacillus casei LC03 | Increased Serum Immunoglobulin A (IgA) Levels | Beneficial | Moderate |
Lactobacillus casei PXN 37 | Enhanced Antipneumococcal IgA Levels in BAL | Beneficial | Moderate |
Lactobacillus casei PXN 37 | Enhanced Resistance to Streptococcus Pneumoniae Infection | Beneficial | Large |
Lactobacillus casei PXN 37 | Improved Immune Cell Counts | Beneficial | Large |
Lactobacillus casei PXN 37 | Improved Pathogen Clearance | Beneficial | Large |
Lactobacillus casei R0215 | Enhanced Antipneumococcal IgA Levels in BAL | Beneficial | Moderate |
Lactobacillus casei R0215 | Improved Bactericidal Function of Phagocytic Cells | Beneficial | Moderate |
Lactobacillus casei R0215 | Improved Immune Response | Beneficial | Large |
Lactobacillus casei SD-5213 | Enhanced Antipneumococcal IgA Levels in BAL | Beneficial | Moderate |
Lactobacillus casei SD-5213 | Improved Respiratory Infection Resistance | Beneficial | Large |
Lactobacillus casei SD-5842 | Enhanced Antipneumococcal IgA Levels in BAL | Beneficial | Moderate |
Lactobacillus casei SD-5842 | Improved Bactericidal Function of Phagocytic Cells | Beneficial | Moderate |
Lactobacillus casei SD-5842 | Improved Resistance to Pneumococcal Infection | Beneficial | Large |
Lactobacillus casei SD5213 | Accelerated Innate Immune Response Recovery | Beneficial | Large |
Lactobacillus casei SD5213 | Improved Pathogen Clearance | Beneficial | Large |
Lactobacillus casei subsp. casei | Improved Immune Cell Function | Beneficial | Large |
Lactobacillus casei subsp. casei | Improved Pathogen Clearance | Beneficial | Large |
Lactobacillus casei subsp. casei | Improved Respiratory Infection Resistance | Beneficial | Large |
Lactobacillus casei subsp. casei | Increased Serum Immunoglobulin A (IgA) Levels | Beneficial | Moderate |
Lactobacillus casei UALc-03 | Enhanced Antipneumococcal IgA Levels in BAL | Beneficial | Moderate |
Lactobacillus casei UALc-03 | Improved Bactericidal Function of Phagocytic Cells | Beneficial | Moderate |
Lactobacillus casei UALc-03 | Improved Immune Mechanisms Against S. pneumoniae | Beneficial | Large |
Lactobacillus casei UALc-03 | Improved Innate Immune Response | Beneficial | Large |
Lactobacillus casei UALc-03 | Improved Resistance to Pneumococcal Respiratory Infection | Beneficial | Large |
Lactobacillus casei VK4 | Enhanced Antipneumococcal IgA Levels in BAL | Beneficial | Moderate |
Lactobacillus genseni | Improved Immune Cell Function | Beneficial | Large |
Lactobacillus genseni | Improved Respiratory Infection Resistance | Beneficial | Large |
Lactobacillus genseni | Increased Serum Immunoglobulin A (IgA) Levels | Beneficial | Moderate |
Lactobacillus genseni | Reduced Lung Damage | Beneficial | Large |
Lactobacillus paracasei 431 | Improved Immune Cell Function | Beneficial | Large |
Lactobacillus paracasei 431 | Improved Pathogen Clearance | Beneficial | Large |
Lactobacillus paracasei 431 | Improved Respiratory Infection Resistance | Beneficial | Large |
Lactobacillus paracasei 431 | Increased Serum Immunoglobulin A (IgA) Levels | Beneficial | Moderate |